{"created":"2023-05-15T12:17:06.037036+00:00","id":788,"links":{},"metadata":{"_buckets":{"deposit":"50c12cbc-a437-421b-adcd-ed96c13313b0"},"_deposit":{"created_by":8,"id":"788","owners":[8],"pid":{"revision_id":0,"type":"depid","value":"788"},"status":"published"},"_oai":{"id":"oai:aino.repo.nii.ac.jp:00000788","sets":["7:74"]},"author_link":["2775","2774"],"item_10002_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2018-03-31","bibliographicIssueDateType":"Issued"},"bibliographicPageEnd":"87","bibliographicPageStart":"73","bibliographicVolumeNumber":"16","bibliographic_titles":[{},{"bibliographic_title":"AINO JOURNAL","bibliographic_titleLang":"en"}]}]},"item_10002_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"1348-480X","subitem_source_identifier_type":"ISSN"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Masatoshi, Takeda","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"2774","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Yukie, Mizoguchi","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"2775","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2023-04-27"}],"displaytype":"detail","filename":"Development of antipsychotics in Japan.pdf","filesize":[{"value":"1.4 MB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"Development of antipsychotics in Japan","url":"https://aino.repo.nii.ac.jp/record/788/files/Development of antipsychotics in Japan.pdf"},"version_id":"d39856ab-0116-4c02-bf89-98b5aaeede0a"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"Chlorpromazine(治療的利用)","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Haloperidol(治療的利用,毒性・副作用)","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Piperazines(治療的利用)","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Quinuclidines(治療的利用,毒性・副作用)","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Sulfones(治療的利用)","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Thiophenes(治療的利用,毒性・副作用)","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"*抗精神病剤(治療的利用,毒性・副作用,薬理学)","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"統合失調症(薬物療法)","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"薬学史","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Dopamine D2 Receptors","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Risperidone(治療的利用,毒性・副作用,薬理学)","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Aripiprazole(治療的利用)","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Blonanserin(治療的利用,薬理学)","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Ziprasidone(治療的利用,薬理学)","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"*医薬品開発","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Iloperidone(治療的利用,薬理学)","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Lurasidone(治療的利用,薬理学)","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Asenapine(治療的利用,毒性・副作用)","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Cariprazine(治療的利用,薬理学)","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Brexpiprazole(治療的利用,薬理学)","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Bitopertin(治療的利用)","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Encenicline(治療的利用,毒性・副作用)","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"ヒト","subitem_subject_language":"en","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"departmental bulletin paper","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Development of antipsychotics in Japan","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Development of antipsychotics in Japan"},{"subitem_title":"日本における抗精神病薬の開発(Development of antipsychotics in Japan)","subitem_title_language":"en"}]},"item_type_id":"10002","owner":"8","path":["74"],"pubdate":{"attribute_name":"公開日","attribute_value":"2022-07-13"},"publish_date":"2022-07-13","publish_status":"0","recid":"788","relation_version_is_last":true,"title":["Development of antipsychotics in Japan"],"weko_creator_id":"8","weko_shared_id":8},"updated":"2023-05-15T12:24:51.536565+00:00"}